- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Allergy Therapeutics (AGY)
Allergy Therapeutics stock price live, this page displays LON AGY stock exchange data. View the AGY premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Allergy Therapeutics real time stock price chart below.
What Is the Allergy Therapeutics Stock Price Today?
The Allergy Therapeutics stock price today is 8.00.
What Is the Stock Symbol for Allergy Therapeutics?
The stock symbol for Allergy Therapeutics is ""AGY.""
What Stock Exchange Does Allergy Therapeutics Trade On?
Allergy Therapeutics is listed and trades on the London stock exchange.
Is Allergy Therapeutics a Good Stock to Buy?
Determining whether Allergy Therapeutics—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AGY quote. (ISIN: GB00B02LCQ05)
What Is the Allergy Therapeutics Stock Price Today?
The Allergy Therapeutics stock price today is 8.00.
What Is the Stock Symbol for Allergy Therapeutics?
The stock symbol for Allergy Therapeutics is ""AGY.""
What Stock Exchange Does Allergy Therapeutics Trade On?
Allergy Therapeutics is listed and trades on the London stock exchange.
Is Allergy Therapeutics a Good Stock to Buy?
Determining whether Allergy Therapeutics—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the AGY quote. (ISIN: GB00B02LCQ05)
London
Currency in GBP
8.00
0.00(0.00%)
Closed·
Fair Value
An estimate of a Allergy Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.86
8.50
52 wk Range
3.80
8.50
AGY Scorecard
Full Analysis
Management has been aggressively buying back shares
Trading near 52-week High
More Info
Fair Value
An estimate of a Allergy Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
7.868.50
52 wk Range
3.808.50
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
AGY Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Allergy Therapeutics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceAnalysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Allergy Therapeutics Company Profile
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders. The company sells injectable and sublingual allergen-specific immunotherapies; and offers treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus. It also develops Grass MATA MPL, a subcutaneous allergen-specific immunotherapy candidate that aims to address the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen; and VLP Peanut, a short-course peanut allergy vaccine. The company operates in Germany, Austria, Netherlands, Switzerland, Italy, Spain, and internationally, as well as the United Kingdom. Allergy Therapeutics plc was founded in 1998 and is headquartered in Worthing, the United Kingdom.
Compare AGY to Peers and Sector
Metrics to compare | AGY | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipAGYPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.1x | −0.3x | −0.5x | |
PEG Ratio | −0.15 | 0.00 | 0.00 | |
Price/Book | −55.3x | 1.9x | 2.6x | |
Price / LTM Sales | 7.1x | 2.2x | 3.2x | |
Upside (Analyst Target) | 52.9% | 58.6% | 42.7% | |
Fair Value Upside | Unlock | 15.3% | 5.8% | Unlock |
Earnings
Latest Release
Mar 31, 2025
EPS / Forecast
-- / --
Revenue / Forecast
34.03M / --
People Also Watch
FAQ
What Stock Exchange Does Allergy Therapeutics Trade On?
Allergy Therapeutics is listed and trades on the London Stock Exchange stock exchange.
What Is the Stock Symbol for Allergy Therapeutics?
The stock symbol for Allergy Therapeutics is "AGY."
What Is the Allergy Therapeutics Market Cap?
As of today, Allergy Therapeutics market cap is 381.32M.
What Is Allergy Therapeutics's Earnings Per Share (TTM)?
The Allergy Therapeutics EPS (TTM) is -0.01.
When Is the Next Allergy Therapeutics Earnings Date?
Allergy Therapeutics will release its next earnings report on 23 Sept 2025.
From a Technical Analysis Perspective, Is AGY a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
How Many Times Has Allergy Therapeutics Stock Split?
Allergy Therapeutics has split 0 times.
How Many Employees Does Allergy Therapeutics Have?
Allergy Therapeutics has 612 employees.
What is the current trading status of Allergy Therapeutics (AGY)?
As of 23 Jul 2025, Allergy Therapeutics (AGY) is trading at a price of 8.00, with a previous close of 8.00. The stock has fluctuated within a day range of 7.86 to 8.50, while its 52-week range spans from 3.80 to 8.50.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.